US approves novel remedy for hayfever, pollen allergies (Update)

April 2, 2014

US regulators on Wednesday approved a French-made remedy for alleviating symptoms of hayfever and certain allergies to grass pollen.

The tablet, called Oralair, dissolves under the tongue and must be taken daily for four months prior to the start of the grass pollen season, and then continued throughout the season.

Pre-approval trials on 2,500 people found that those who took the remedy experienced a 16 to 30 percent reduction in symptoms, which can include sneezing, runny nose, and itchy, watery eyes.

Manufactured by Stallergenes S.A. of Antony, France, the tablet contains freeze-dried extracts from the pollens of five grasses, including Kentucky Blue Grass, Orchard, Perennial Rye, Sweet Vernal and Timothy.

It is the first US Food and Drug Administration-approved allergen extract that can be dissolved under the tongue, the agency said in a statement.

"The approval of Oralair provides an alternative to allergy shots that must be given in a health care provider's office," said Karen Midthun, director of the FDA's Center for Biologics Evaluation and Research.

"While there is no cure for grass pollen allergies, they can be managed through treatment and avoiding exposure to the pollen."

These allergies affect some 30 million people in the United States and more than 500 million worldwide, according to the FDA.

Explore further: Get ready for spring - hay fever worse in spring than summer

Related Stories

Get ready for spring - hay fever worse in spring than summer

December 21, 2011

Hay fever (runny nose, sneezing, itchy eyes) is caused by an allergy to pollen, and most commonly to grass pollen. These tiny grains bring misery to sufferers through spring and summer and pollen levels are often included ...

Merck: FDA reviewing tablet to eliminate allergy

March 27, 2013

Drugmaker Merck & Co. says federal regulators are reviewing its application to sell a new type of treatment for grass pollen allergy that gradually reduces allergy symptoms over time, rather than just temporarily relieving ...

Merck says FDA reviewing its ragweed allergy therapy

May 8, 2013

Drugmaker Merck & Co. says the Food and Drug Administration is reviewing its second application to sell a new type of allergy treatment meant to gradually reduce allergic reactions over time, rather than just relieving sneezing, ...

Spring is here, but so are allergies

March 21, 2014

Spring has finally arrived in Cincinnati, but soon to follow will be the coughing, sneezing and wheezing that comes with allergies, hay fever and asthma—three warm weather killjoys most could do without.

Recommended for you

Snapshot turns T cell immunology on its head

October 6, 2015

Challenging a universally accepted, longstanding consensus in the field of immunity requires hard evidence. New research from the Australian Research Council Centre of excellence in advanced Molecular imaging has shown the ...

Four gut bacteria decrease asthma risk in infants

September 30, 2015

New research by scientists at UBC and BC Children's Hospital finds that infants can be protected from getting asthma if they acquire four types of gut bacteria by three months of age. More than 300 families from across Canada ...

Flu infection reveals many paths to immune response

September 28, 2015

A new study of influenza infection in an animal model broadens understanding of how the immune system responds to flu virus, showing that the process is more dynamic than usually described, engaging a broader array of biological ...

Immune cells may help fight against obesity

September 15, 2015

While a healthy lifestyle and "good genes" are known to help prevent obesity, new research published on September 15 in Immunity indicates that certain aspects of the immune system may also play an important role. In the ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.